In 2001, glucoraphanin from broccoli seeds, was first used in dietary supplements, functional foods and green tea in the United States. In 2016, glucoraphanin extracted from broccoli seeds, received GRAS approval from the FDA. In 2017, aqueous extract of seed of broccoli containing 13-20% glucoraphanin was officially approved as a new food raw material by the National Health Commission of China.

At present, there are two kinds of broccoli seed extracts: glucoraphanin and sulforaphane, which are mainly used in the fields of food, health products and cosmetics. Due to the high commercialization of health care products, Europe and North America have become the main markets of broccoli seed extract in the world. The Asia Pacific region has the highest growth rate in the global market and the most potential market in the future. The U.S. and Canada accounted for 68% of the global market, while China accounts for only 12% showing huge market prospects.